Penetrating anti-DNA monoclonal antibodies induce activation of human peripheral blood mononuclear cells

Journal of Autoimmunity

Volumn 11, Issue 5, 1998, Pages 563-571

  Portales Pérez, Diana ^a   Alarcón Segovia, Donato ^d   Llorente, Luis ^d   Ruíz Argüelles, Alejandro ^b   Abud Mendoza, Carlos ^a   Baranda, Lourdes ^a   De La Fuente, Hortensia ^a   Ternynck, Thèrese ^c   González Amaro, Roberto ^a  

^a UNIVERSIDAD AUTÓNOMA DE SAN LUIS POTOSÍ   (Mexico)

^b Laboratorios Clinicos de Puebla   (Mexico)

^c INSTITUT PASTEUR   (France)

^d NONE

Author keywords

Anti DNA; Antibody penetration; Autoantibodies; Autoimmunity; Lymphocyte activation; Systemic lupus erythematosus

Indexed keywords

CD69 ANTIGEN; CD71 ANTIGEN; DNA ANTIBODY; FAS ANTIGEN; IMMUNOGLOBULIN G ANTIBODY; INTERCELLULAR ADHESION MOLECULE 1; MONOCLONAL ANTIBODY;

ANTIGEN EXPRESSION; APOPTOSIS; AUTOIMMUNITY; CONFERENCE PAPER; CONTROLLED STUDY; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; LYMPHOCYTE ACTIVATION; MONONUCLEAR CELL; PATHOGENESIS; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 0032192045     PISSN: 08968411     EISSN: None     Source Type: Journal    
DOI: 10.1006/jaut.1998.0218     Document Type: Conference Paper

References (46)

1. 1. Mills J.A. 1994. Systemic lupus erythematosus. New Engl. J. Med. 330: 1871-1874
2. 2. Sany J. 1990. Pathogenic role of antinuclear antibodies in lupus disease. Ann. Med. Interne. Paris 141: 222-226
3. 3. Zack D.J., Yamamoto K., Wong A.L., Stempniak M., French C., Weisbart R.H. 1995. DNA mimics a self-protein that may be a target for some anti-DNA antibodies in systemic lupus erythematosus. J. Immunol. 154: 1987-1994
4. 4. Golan T.D., Gharavi A.E., Elkon K.B. 1993. Penetration of autoantibodies into epithelial living cells. J. Invest. Dermatol. 100: 316-322
5. 5. Golan T.D., Sigal D., Sabo E., Shemuel Z., Guedj D., Weinberger A. 1997. The penetrating potential of autoantibodies into live cells in vitro coincides with the in vivo staining of epidermal nuclei. Lupus 6: 18-26
6. 6. Galoppin L., Saurat J.H. 1981. In vitro study of the binding of anti-riboprotein antibodies to the nucleus of isolated living keratinocytes. J. Invest. Dermatol. 76: 264-267
7. 7. Alarcón-Segovia D., Ruíz-Argüelles A., Llorente L. 1996. Broken Dogma: penetration autoantibodies into living cells. Immunol. Today 17: 163-164
8. 8. McCauliffe D.P. 1996. Antibody penetration into the cells of mice and men. J. Invest. Dermatol. 107: 3-4
9. 9. Ma J., Chapman G.V., Chen S.L., Melick G., Penny R., Breit S.N. 1991. Antibody penetration of viable human cells. I. Increased penetration of human lymphocytes by anti-DNA IgG. Clin. Exp. Immunol. 84: 83-91
10. 10. Alarcón-Segovia D., Ruíz-Argüelles A., Fishbein E. 1979. Antibody penetration into living cells, I: Intranuclear immunoglobulin in peripheral blood mononuclear cells in mixed connective tissue disease and systemic lupus erythematosus. Clin. Exp. Immunol. 35: 364-375
11. 11. Zack D.J., Stempniak M., Wong A.L., Taylor C., Weisbart R.H. 1996. Mechanism of cellular penetration and nuclear localization of an anti-double strand DNA autoantibody. J. Immunol. 157: 2082-2088
12. 12. Ma J., King N., Chen S.L., Penny R., Breit S.N. 1993. Antibody penetration of viable human cells, II: Anti-RNP antibodies binding to RNP antigen expressed on cell surface, which may mediate the antibody internalization. Clin. Exp. Immunol. 93: 396-404
13. 13. Alarcón-Segovia D., Ruíz-Argüelles A., Fishbein E. 1978. Antibody to nuclear ribonucleoprotein penetrates live human mononuclear cells through Fc receptors. Nature 271: 67-69
14. 14. Termaat R.M., Assmann K.J., Dijkman H.B., van Gompel F., Smeenk R.J., Berden J.H. 1992. Anti-DNA antibodies can bind to the glomerulus via two distinct mechanisms. Kidney Int. 42: 1363-1371
15. 15. Jacob L., Viard J.P., Allenet B., Anin M.F., Slama F.B., Vandekerckhove J., Primo J., Markovits J., Jacob F., Bach J.F. 1989. A monoclonal anti-double-stranded DNA autoantibody binds to a 94 kDa cell-surface protein on various cell types via nucleosomes or a DNA-histone complex . Proc. Natl. Acad. Sci. USA 86: 4669-4673
16. 16. Koutouzov S., Cabrespines A., Amoura Z., Chabre H., Lotton C., Bach J.F. 1996. Binding of nucleosomes to a cell surface receptor: redistribution and endocytosis in the presence of lupus antibodies. Eur. J. Immunol. 26: 472-486
17. 17. Raz E., Ben-Bassat H., Davidi T., Shlomai Z., Eilat D. 1993. Cross-reactions of anti-DNA autoantibodies with cell surface proteins. Eur. J. Immunol. 23: 383-390
18. 18. Yanase K., Smith R.M., Cizman B., Foster M.H., Peachey L.D., Jarett L., Madaio M.P. 1994. A subgroup of murine monoclonal anti-deoxyribonucleic acid antibodies traverse the cytoplasm and enter the nucleus in a time-and temperature-dependent manner. Lab. Invest. 71: 52-60
19. 19. Schlossman S.F., Boumsell L., Gilks W., Harlan W., Kishimoto T., Morimoto C., Ritz J., Shaw S., Silverstein R.L., Springer T.A., Tedder T.F., Todd R.F. 1994. Leucocyte typing; V: white cell differentiation antigens. Oxford University Press, Oxford
20. 20. Wesslborg S., Janssen O., Kabelitz D. 1993. Induction of activation-driven death (apoptosis) in activated but not resting peripheral blood T cells. J. Immunol. 150: 4338-4345
21. 21. Nagafuchi H., Suzuki N., Mizuchima Y., Sakana T. 1993. Constitutive expression of IL-6 receptors and their role in the excessive B cell function in patients with systemic lupus erythematosus. J. Immunol. 151: 6525-6534
22. 22. Llorente L., Richaud-Patin Y., Wijdenes J., Alcocer-Varela J., Maillot M.C., Durand-Gasselin I., Morel-Fourrier B., Galanaud P., Emilie D. 1993. Spontaneous production of interleukin-10 by B lymphocytes and monocytes in systemic lupus erythematosus. Eur. Cytokine Net. 4: 421-430
23. 23. Emlen W., Niebur J., Kadera R. 1994. Accelerated in vitro apoptosis in lymphocytes from patients with systemic lupus erythematosus. J. Immunol. 152: 3685-3692
24. 24. Alarcón-Segovia D., Llorente L., Ruíz-Argüelles A. 1996. The penetration of autoantibodies into cells may induce tolerance to self by apoptosis of autoreactive lymphocytes and cause autoimmune disease by dysregulation and/or cell damage. J. Autoimmunity 9: 295-300
25. 25. Okawatakatsuji M., Aotsuka S., Uwatoko S., Sumiya M., Yokohari R. 1995. Enhanced synthesis of cytokines by peripheral blood monocytes cultured in the presence of autoantibodies against U1-ribonucleoprotein and/or negatively charged molecules: implication in the pathogenesis of pulmonary hypertension in mixed connective tissue disease (MCTD). Clin. Exp. Immunol. 98: 427-433
26. 26. Lai K.N., Leung J.C.K., Lai K.B., Li P.K.T., Lai C.K.W. 1996. Anti-DNA autoantibodies stimulate the release of interleukin-1 and interleukin-6 from endothelial cells. J. Pathol. 178: 451-457
27. 27. Luque A., Gómez-Gutiérrez M., Puzon W., Takada Y., Sánchez-Madrid F., Cabañas C. 1995. Activated conformations of VLA integrins detected by a group of antibodies specific for a novel regulatory region (355-425) of the common β1 chain. J. Biol. Chem. 127: 11067-11075
28. 28. Hernández-Caselles T., Rubio G., Campanero M.R., del Pozzo M.A., Muro M., Sánchez-Madrid F., Aparicio P. 1993. ICAM-3, the third LFA-1 counterreceptor, is a co-stimulatory molecule for both resting and activated T lymphocytes . Eur. J. Immunol. 23: 2799-2806
29. 29. Portales-Pérez D.P., González-Amaro R., Quevedo M., Sánchez-Madrid F. 1996. Antígenos de activación linfocitaria. Rev. Mex. Rheumatol. 11: 65-71
30. 30. Matiba B., Mariani S.M., Krammer P.H. 1997. The CD95 system and the death of a lymphocyte. Sem. Immunol. 9: 59-68
31. 2+ during activation of lymphocytes from patients with systemic lupus erythematosus. Lupus 6: 48-56
32. 32. Georgescu L., Vakkalanka R.K., Elkon K.B., Crow M.K. 1997. Interleukin-10 promotes activation-induced cell death of SLE lymphocytes mediated by Fas ligand. J. Clin. Invest. 100: 2622-2633
33. 33. Collins T.L., Kassner P.D., Bierer B.E., Burakoff S.J. 1994. Adhesion receptors in lymphocyte activation. Curr. Opin. Immunol. 6: 385-393
34. 34. Horwitz D.A., Sthol W. 1993. Abnormalities in T lymphocytes (in systemic lupus erythematosus). In Dubois' lupus erythematosus. D.J. Wallace, B.H. Hans, eds. Lea & Febiger, Philadelphia, pp. 83-96
35. 35. Horwitz D.A., Garret M.A. 1977. Lymphocyte reactivity to mitogens in subjects with systemic lupus erythematosus, rheumatoid arthritis and scleroderma. Clin. Exp. Immunol. 27: 92-96
36. 36. González-Amaro R., Portales-Pérez D.P., Baranda L., Abud-Mendoza C., Llorente L., Richaud-Patin Y., Alcocer-Varela J., Alarcón-Segovia D. 1998. Role of IL-10 in the abnormalities of early cell activation events of lymphocytes from patients with systemic lupus erythematosus. J. Autoimmuno. In press
37. 37. Santis A.G., Campanero M.R., Alonso J.L., Tugores A., Alonso M.A., Yagüe E., Pivel J.P., Sánchez-Madrid F. 1992. Tumor necrosis factor-α production induced in T lymphocytes through the AIM/CD69 activation pathway. Eur. J. Immunol. 22: 1253-1259
38. 38. Cebrián M., Redondo J.M., López-Rivas A., Rodríguez-Torduchi G., Ortíz de Landázuri M.O., Sánchez-Madrid F. 1989. Expression and function of AIM, an activation inducer molecule of human lymphocytes is dependent on the activation of protein kinase C. Eur. J. Immunol. 19: 809-815
39. 39. Fernández-Herrera J., López-Cabrera M., Fernández-Ruiz E., Sánchez-Madrid F., González-Amaro R. 1996. CD69 cell expression and TNF-α immunoreactivity in halo nevi inflammatory cell infiltrates. Br. J. Dermatol. 134: 388-393
40. 40. Baranda L., Torres-Alvarez B., Cortés-Franco R., Moncada B., Portales-Pérez D.P., González-Amaro R. 1997. Involvement of cell adhesion and activation molecules in the pathogenesis of erythema dyschromicum perstans (ashy dermatitis). The effect of clofazimine therapy. Arch. Dermatol. 133: 325-329
41. 41. Barclay A.N., Birkeland M.L., Brown M.H., Beyer A.D., Davis S.J., Somoza C., Williams A.F. 1993. The leucocyte antigen facts book. Academic Press, London
42. 42. del Pozzo M.A., Sánchez-Mateos P., Nieto M., Sánchez-Madrid F. 1995. Chemokines regulate cellular polarization and adhesion receptor redistribution during redistribution during lymphocyte interaction with endothelium and extracellular matrix. Involvement of cAMP signaling pathway. J. Cell Biol. 131: 495-504
43. 43. López-Briones S., Portales-Pérez D.P., Baranda L., de la Fuente H., Rosenstein Y., González-Amaro R. 1998. Stimulation through CD50 but not CD69 preferentially induces apoptosis of TCR+ human peripheral blood lymphocytes. Cell. Adhes. Commun. In press
44. 44. Alarcón-Segovia D., Ruíz-Argüelles A., Llorente L. 1979. Antibody penetration into living cells, II: anti-ribonucleoprotein IgG penetrates into T-γ lymphocytes causing their deletion and the abrogation of suppressor function. J. .Immunol. 122: 1855-1862
45. 45. Ohsako O., Hara M., Harigai M., Fukasawa C., Kashiwazaki S. 1994. Expression and function of Fas antigen and bcl-2 in human systemic lupus erythematosus lymphocytes. Clin. Immunol. Immunopathol. 73: 109-114
46. 46. Vlahakos D., Foster M.H., Ucci A.A., Barrett K.J., Datta S.K., Madaio M.P. 1992. Murine monoclonal anti-DNA antibodies penetrate cells, bind to nuclei, and induce glomerular proliferation and proteinuria in vivo. J. Am. Soc. Nephrol. 2: 1345-1354